Analysts at the **Royal Bank of Canada** have increased their target price for **Calian Group** (TSE:CGY) from **C$58.00** to **C$66.00**, reflecting a positive outlook for the stock. This adjustment, detailed in a report released on **October 26, 2023**, suggests a potential upside of approximately **22.93%** based on the stock’s previous close. The bank currently maintains an “outperform” rating for Calian Group, indicating confidence in its future performance.
Other analysts have also weighed in on Calian Group’s stock performance. **Ventum Financial** downgraded their price target from **C$60.00** to **C$58.00** while retaining a “buy” rating. This revision was made in a research note dated **August 14, 2023**. Similarly, **CIBC** revised its price target from **C$59.00** to **C$62.00**, also granting the stock an “outperform” designation in a report published on **October 29, 2023**. Additionally, **Desjardins** lowered their target from **C$62.00** to **C$59.00**, maintaining a “buy” rating.
Currently, a consensus rating of “Buy” exists for Calian Group, with the average target price set at **C$63.80**, according to **MarketBeat.com**. With five research analysts endorsing a “Buy” rating, the stock is seen as a favorable investment opportunity.
Calian Group’s Market Position and Revenue Streams
Calian Group operates across four primary segments: **Advanced Technologies**, **Health**, **Learning**, and **Information Technology**. The **Health** segment is the most lucrative, contributing significantly to overall revenue. The company serves a diverse range of industries, including health, defense, security, aerospace, engineering, AgTech, and IT.
The Health segment encompasses various services, such as **Clinical Services**, **Nursing Services**, **Psychological Services**, and **Medical Property Management**. This broad service offering positions Calian Group as a key player in essential sectors, ensuring a steady stream of income.
As of the latest trading session, Calian Group shares have increased by **3.5%**, reflecting a positive response to the recent analysts’ reports. With the adjustments made by several financial institutions, investors are closely monitoring the stock for further developments.
For those interested in following the latest updates on Calian Group and related companies, MarketBeat.com offers a daily newsletter summarizing news and analysts’ ratings.
